375 related articles for article (PubMed ID: 16937447)
21. Characterization of humoral and CD4+ cellular responses after genetic immunization with retroviral vectors expressing different forms of the hepatitis B virus core and e antigens.
Sällberg M; Townsend K; Chen M; O'Dea J; Banks T; Jolly DJ; Chang SM; Lee WT; Milich DR
J Virol; 1997 Jul; 71(7):5295-303. PubMed ID: 9188598
[TBL] [Abstract][Full Text] [Related]
22. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.
Wang S; Qiu L; Liu G; Li Y; Zhang X; Jin W; Gao GF; Kong X; Meng S
Vaccine; 2011 Aug; 29(37):6342-51. PubMed ID: 21600951
[TBL] [Abstract][Full Text] [Related]
23. Coimmunization with RANTES plasmid polarized Th1 immune response against hepatitis B virus envelope via recruitment of dendritic cells.
Ma K; Xu W; Shao X; Yanyue ; Hu L; Xu H; Yuan Z; Zheng X; Xiong S
Antiviral Res; 2007 Nov; 76(2):140-9. PubMed ID: 17655942
[TBL] [Abstract][Full Text] [Related]
24. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
[TBL] [Abstract][Full Text] [Related]
25. SIV antigen-specific effects on immune responses induced by vaccination with DNA electroporation and plasmid IL-12.
Lindsay RW; Ouellette I; Arendt HE; Martinez J; DeStefano J; Lopez M; Pavlakis GN; Chiuchiolo MJ; Parks CL; King CR
Vaccine; 2013 Oct; 31(42):4749-58. PubMed ID: 23954384
[TBL] [Abstract][Full Text] [Related]
26. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection.
Li J; Ge J; Ren S; Zhou T; Sun Y; Sun H; Gu Y; Huang H; Xu Z; Chen X; Xu X; Zhuang X; Song C; Jia F; Xu A; Yin X; Du SX
Vaccine; 2015 Aug; 33(35):4247-54. PubMed ID: 25858855
[TBL] [Abstract][Full Text] [Related]
28. Optimization of immune responses induced by therapeutic vaccination with cross-reactive antigens in a humanized hepatitis B surface antigen transgenic mouse model.
Bourgine M; Dion S; Godon O; Guillen G; Michel ML; Aguilar JC
Virology; 2012 Aug; 430(1):10-9. PubMed ID: 22591777
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of immune responses to the hepatitis B virus core protein through DNA vaccines with a DNA fragment encoding human IL-1beta 163-171 peptide.
Shao HJ; Chen L; Shen MS; Yu GF
Acta Virol; 2003; 47(4):217-21. PubMed ID: 15068376
[TBL] [Abstract][Full Text] [Related]
30. A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice.
Buchmann P; Dembek C; Kuklick L; Jäger C; Tedjokusumo R; von Freyend MJ; Drebber U; Janowicz Z; Melber K; Protzer U
Vaccine; 2013 Feb; 31(8):1197-203. PubMed ID: 23306359
[TBL] [Abstract][Full Text] [Related]
31. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice].
Li L; Tian YJ; Shen H; Zhao XP; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):275-9. PubMed ID: 19403026
[TBL] [Abstract][Full Text] [Related]
32. Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting.
Li W; Li S; Hu Y; Tang B; Cui L; He W
Vaccine; 2008 Jun; 26(26):3282-90. PubMed ID: 18472194
[TBL] [Abstract][Full Text] [Related]
33. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine.
Channarong S; Mitrevej A; Sinchaipanid N; Usuwantim K; Kulkeaw K; Chaicumpa W
Asian Pac J Allergy Immunol; 2007 Dec; 25(4):233-42. PubMed ID: 18402297
[TBL] [Abstract][Full Text] [Related]
34. [Immunogenicity of new DNA vaccine encoding for hepatitis B virus core antigen].
Xing YP; Huang ZH; Wang SX; Cai J; Li J; Lu S
Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):338-40. PubMed ID: 15225426
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids.
Geissler M; Gesien A; Tokushige K; Wands JR
J Immunol; 1997 Feb; 158(3):1231-7. PubMed ID: 9013964
[TBL] [Abstract][Full Text] [Related]
36. Adenovirus Vector Harboring the HBcAg and Tripeptidyl Peptidase II Genes Induces Potent Cellular Immune Responses In Vivo.
Tan Q; Ma S; Hu J; Chen X; Yu Y; Tang Z; Zang G
Cell Physiol Biochem; 2017; 41(2):423-438. PubMed ID: 28214886
[TBL] [Abstract][Full Text] [Related]
37. Cytokine-facilitated priming of CD8+ T cell responses by DNA vaccination.
Kwissa M; Kröger A; Hauser H; Reimann J; Schirmbeck R
J Mol Med (Berl); 2003 Feb; 81(2):91-101. PubMed ID: 12601525
[TBL] [Abstract][Full Text] [Related]
38. DNA prime-adenovirus boost immunization induces a vigorous and multifunctional T-cell response against hepadnaviral proteins in the mouse and woodchuck model.
Kosinska AD; Johrden L; Zhang E; Fiedler M; Mayer A; Wildner O; Lu M; Roggendorf M
J Virol; 2012 Sep; 86(17):9297-310. PubMed ID: 22718818
[TBL] [Abstract][Full Text] [Related]
39. [Enhancement of immune responses to hepatitis B DNA vaccine by superantigen SEA in mice].
Jin YW; Li P; Xu QB; Liu X; Huang W; Wang YL; Cao C; Ma QJ
Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):681-5. PubMed ID: 16285504
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of IL-15 on the generation, maintenance and cytotoxic potential of adaptive cellular responses induced by DNA vaccination.
Li J; Valentin A; Ng S; Beach RK; Alicea C; Bergamaschi C; Felber BK; Pavlakis GN
Vaccine; 2015 Feb; 33(9):1188-96. PubMed ID: 25559187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
